BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11714541)

  • 1. Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancer.
    Buccheri G; Ferrigno D
    Lung Cancer; 2001 Dec; 34(3):433-40. PubMed ID: 11714541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proportional weight loss in six months as a risk factor for mortality in stage IV non-small cell lung cancer.
    Watte G; Nunes CHA; Sidney-Filho LA; Zanon M; Altmayer SPL; Pacini GS; Barros M; Moreira ALS; Alves RJV; Zelmanowicz AM; Matata BM; Moreira JDS
    J Bras Pneumol; 2018; 44(6):505-509. PubMed ID: 30726327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-small cell bronchogenic carcinoma in advanced stages: prognostic value of weight loss and clinical implications].
    Gullón J; Fernández R; Rubinos G; Medina A; Suárez I; González I
    Arch Bronconeumol; 2001 Dec; 37(11):477-81. PubMed ID: 11734136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of weight change during the course of concurrent chemoradiation therapy on outcomes in stage IIIB non-small cell lung cancer patients: retrospective analysis of 425 patients.
    Topkan E; Parlak C; Selek U
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):697-704. PubMed ID: 24035331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between body mass index, weight loss and overall survival in patients with advanced lung cancer.
    Oswalt C; Liu Y; Pang H; Le-Rademacher J; Wang X; Crawford J
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2650-2660. PubMed ID: 36268548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer.
    Buccheri G; Ferrigno D; Vola F
    Lung Cancer; 1993 Oct; 10(1-2):21-33. PubMed ID: 8069601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy].
    Takifuji N; Fukuoka M; Negoro S; Takada M; Kusunoki Y; Matsui K; Masuda N; Ryu S; Sakai N; Kubota K
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):429-34. PubMed ID: 2157364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study.
    Berghmans T; Ameye L; Willems L; Paesmans M; Mascaux C; Lafitte JJ; Meert AP; Scherpereel A; Cortot AB; Cstoth I; Dernies T; Toussaint L; Leclercq N; Sculier JP;
    Lung Cancer; 2013 Nov; 82(2):340-5. PubMed ID: 24007627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer.
    Cheng YL; Lee SC; Harn HJ; Chen CJ; Chang YC; Chen JC; Yu CP
    Eur J Cardiothorac Surg; 2003 Feb; 23(2):221-8. PubMed ID: 12559346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
    Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
    BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
    Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer.
    Yoshida Y; Murayama T; Sato Y; Suzuki Y; Saito H; Nomura Y
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):507-14. PubMed ID: 26366891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
    Paesmans M; Sculier JP; Libert P; Bureau G; Dabouis G; Thiriaux J; Michel J; Van Cutsem O; Sergysels R; Mommen P
    J Clin Oncol; 1995 May; 13(5):1221-30. PubMed ID: 7738625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis in lung cancer: physicians' opinions compared with outcome and a predictive model.
    Muers MF; Shevlin P; Brown J
    Thorax; 1996 Sep; 51(9):894-902. PubMed ID: 8984699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.
    Omote N; Hashimoto N; Morise M; Sakamoto K; Miyazaki S; Ando A; Nakahara Y; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3541-3547. PubMed ID: 29270008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in older patients with advanced non-small cell lung cancer in China.
    Su Q; Sun YP; Liu YH; Li Z; Yang HY; Sun ZG; Cao BW; Jia JH
    Tumori; 2014; 100(1):69-74. PubMed ID: 24675494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery.
    Nakagawa T; Toyazaki T; Chiba N; Ueda Y; Gotoh M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):560-6. PubMed ID: 27252238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.